{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:56:55Z","timestamp":1786985815707,"version":"build-2736575974"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.cca.2023.117226","type":"journal-article","created":{"date-parts":[[2023,1,9]],"date-time":"2023-01-09T10:49:26Z","timestamp":1673261366000},"page":"117226","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Association of lipoprotein(a) with left ventricular hypertrophy in patients with new-onset acute myocardial infarction: A large cross-sectional study"],"prefix":"10.1016","volume":"540","author":[{"given":"Zhen-Wei","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng-Jue","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nai-Feng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.cca.2023.117226_b0005","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1007\/s10741-021-10134-5","article-title":"Left ventricular hypertrophy and sudden cardiac death","volume":"27","author":"Giamouzis","year":"2022","journal-title":"Heart. Fail. Rev."},{"issue":"1","key":"10.1016\/j.cca.2023.117226_b0010","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.pcad.2019.11.009","article-title":"Left ventricular hypertrophy and hypertension","volume":"63","author":"Yildiz","year":"2020","journal-title":"Prog. Cardiovasc. Dis."},{"issue":"5","key":"10.1016\/j.cca.2023.117226_b0015","doi-asserted-by":"crossref","first-page":"376","DOI":"10.7326\/0003-4819-131-5-199909070-00009","article-title":"Potential new cardiovascular risk factors: left ventricular hypertrophy, homocysteine, lipoprotein(a), triglycerides, oxidative stress, and fibrinogen","volume":"131","author":"Harjai","year":"1999","journal-title":"Ann. Intern. Med."},{"issue":"1","key":"10.1016\/j.cca.2023.117226_b0020","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.pcad.2014.05.003","article-title":"Impact of echocardiographic left ventricular geometry on clinical prognosis","volume":"57","author":"Lavie","year":"2014","journal-title":"Prog. Cardiovasc. Dis."},{"key":"10.1016\/j.cca.2023.117226_b0025","doi-asserted-by":"crossref","unstructured":"C.N. Bang, E.Z. Soliman, L.M. Simpson, et al., Electrocardiographic Left Ventricular Hypertrophy Predicts Cardiovascular Morbidity and Mortality in Hypertensive Patients: The ALLHAT Study. Am. J. Hypertens. 2017;30(9):914-922. doi: https:\/\/doi.org\/10.1093\/ajh\/hpx067.","DOI":"10.1093\/ajh\/hpx067"},{"issue":"11","key":"10.1016\/j.cca.2023.117226_b0030","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.007564","article-title":"Combining ECG criteria for left ventricular hypertrophy improves risk prediction in patients with hypertension","volume":"6","author":"Okin","year":"2017","journal-title":"JAHA"},{"issue":"8","key":"10.1016\/j.cca.2023.117226_b0035","doi-asserted-by":"crossref","first-page":"e012457","DOI":"10.1161\/JAHA.119.012457","article-title":"Is electrocardiography-left ventricular hypertrophy an obsolete marker for determining heart failure risk with hypertension?","volume":"8","author":"Ferdinand","year":"2019","journal-title":"J. Am. Heart. Assoc."},{"key":"10.1016\/j.cca.2023.117226_b0040","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2021.639993","article-title":"The association between left ventricular hypertrophy and the occurrence and prognosis of atrial fibrillation: a meta-analysis","volume":"8","author":"Xiang","year":"2021","journal-title":"Front. Cardiovasc. Med."},{"issue":"10","key":"10.1016\/j.cca.2023.117226_b0045","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.amjmed.2008.05.034","article-title":"Left ventricular hypertrophy and cardiovascular mortality by race and ethnicity","volume":"121","author":"Havranek","year":"2008","journal-title":"Am. J. Med."},{"issue":"6","key":"10.1016\/j.cca.2023.117226_b0050","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1067\/mhj.2000.111112","article-title":"Left ventricular hypertrophy as a predictor of coronary heart disease mortality and the effect of hypertension","volume":"140","author":"Brown","year":"2000","journal-title":"Am. Heart. J."},{"key":"10.1016\/j.cca.2023.117226_b0055","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1699-0463.1963.tb01808.x","article-title":"A new serum type system in man\u2013the LP system","volume":"59","author":"Berg","year":"1963","journal-title":"Acta. Pathol. Microbiol. Scand."},{"issue":"6","key":"10.1016\/j.cca.2023.117226_b0060","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.jacc.2016.11.042","article-title":"A Test in Context: Lipoprotein(a): Diagnosis, Prognosis, Controversies, and Emerging Therapies","volume":"69","author":"Tsimikas","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"issue":"8","key":"10.1016\/j.cca.2023.117226_b0065","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1194\/jlr.R067314","article-title":"Structure, function, and genetics of lipoprotein (a)","volume":"57","author":"Schmidt","year":"2016","journal-title":"J. Lipid. Res."},{"issue":"1","key":"10.1016\/j.cca.2023.117226_b0070","doi-asserted-by":"crossref","DOI":"10.1161\/ATV.0000000000000147","article-title":"Lipoprotein(a): A Genetically Determined, Causal, and Prevalent Risk Factor for Atherosclerotic Cardiovascular Disease: A Scientific Statement From the American Heart Association","volume":"42","author":"Reyes-Soffer","year":"2022","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"7","key":"10.1016\/j.cca.2023.117226_b0075","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1001\/jamacardio.2022.0987","article-title":"Lipoprotein(a) and its Significance in Cardiovascular Disease: A Review","volume":"7","author":"Duarte Lau","year":"2022","journal-title":"JAMA. Cardiol"},{"key":"10.1016\/j.cca.2023.117226_b0080","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ejim.2021.04.012","article-title":"Very low lipoprotein(a) and increased mortality risk after myocardial infarction","volume":"91","author":"Wohlfahrt","year":"2021","journal-title":"Eur. J. Intern. Med."},{"key":"10.1016\/j.cca.2023.117226_b0085","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ejim.2016.08.018","article-title":"Serum lipoprotein(a) concentration as long-term predictor of cardiovascular mortality in a large sample of subjects in primary cardiovascular prevention: data from the Brisighella Heart Study","volume":"37","author":"Fogacci","year":"2017","journal-title":"Eur. J. Intern. Med."},{"issue":"2","key":"10.1016\/j.cca.2023.117226_b0090","doi-asserted-by":"crossref","first-page":"103","DOI":"10.24920\/004066","article-title":"Association Between Lipid Profiles and Left Ventricular Hypertrophy: New Evidence from a Retrospective Study","volume":"37","author":"Xue-Wei","year":"2022","journal-title":"Chin. Med. Sci. J."},{"key":"10.1016\/j.cca.2023.117226_b0095","doi-asserted-by":"crossref","unstructured":"American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2013;36 Suppl 1(Suppl 1):S67-S74. doi:10.2337\/dc13-S067.","DOI":"10.2337\/dc13-S067"},{"issue":"5","key":"10.1016\/j.cca.2023.117226_b0100","first-page":"596","article-title":"Hypertension Canada's 2020 Comprehensive Guidelines for the Prevention, Diagnosis, Risk Assessment, and Treatment of Hypertension in Adults and Children","volume":"36","author":"Rabi","year":"2020","journal-title":"Can. J. Cardiol."},{"key":"10.1016\/j.cca.2023.117226_b0105","unstructured":"China Joint Committee for the Prevention and treatment of Adult Dyslipidemia. Guidelines for prevention and treatment of dyslipidemia in Chinese adults. Chinese Journal of Cardiovascular Diseases. 2007;35(5):390-419."},{"issue":"4","key":"10.1016\/j.cca.2023.117226_b0110","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1194\/jlr.R061648","article-title":"Lipoprotein (a) measurements for clinical application","volume":"57","author":"Marcovina","year":"2016","journal-title":"J. Lipid. Res."},{"issue":"10","key":"10.1016\/j.cca.2023.117226_b0115","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.1681\/ASN.2006040368","article-title":"Modified Glomerular Filtration Rate Estimating Equation for Chinese Patients with Chronic Kidney Disease","volume":"17","author":"Ma","year":"2006","journal-title":"JASN"},{"issue":"10075","key":"10.1016\/j.cca.2023.117226_b0120","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/S0140-6736(16)32064-5","article-title":"Chronic Kidney Disease","volume":"389","author":"Webster","year":"2017","journal-title":"Lancet."},{"issue":"18","key":"10.1016\/j.cca.2023.117226_b0125","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1161\/CIRCULATIONAHA.120.045708","article-title":"The Universal Definition of Myocardial Infarction: Present and Future","volume":"141","author":"Sandoval","year":"2020","journal-title":"Circulation."},{"issue":"6","key":"10.1016\/j.cca.2023.117226_b0130","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1161\/01.CIR.58.6.1072","article-title":"Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements","volume":"58","author":"Sahn","year":"1978","journal-title":"Circulation."},{"issue":"6","key":"10.1016\/j.cca.2023.117226_b0135","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/0002-9149(86)90771-X","article-title":"Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings","volume":"57","author":"Devereux","year":"1986","journal-title":"Am. J. Cardiol."},{"issue":"12","key":"10.1016\/j.cca.2023.117226_b0140","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1093\/ehjci\/jew082","article-title":"Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging","volume":"17","author":"Nagueh","year":"2016","journal-title":"Eur. Heart. J. Cardiovasc. Imaging."},{"issue":"12","key":"10.1016\/j.cca.2023.117226_b0145","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1016\/j.jcmg.2020.07.017","article-title":"Left Ventricular Structural and Functional Alterations in Patients With Pheochromocytoma\/Paraganglioma Before and After Surgery","volume":"13","author":"Dobrowolski","year":"2020","journal-title":"JACC. Cardiovasc. Imaging."},{"issue":"4","key":"10.1016\/j.cca.2023.117226_b0150","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1161\/01.CIR.55.4.613","article-title":"Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method","volume":"55","author":"Devereux","year":"1977","journal-title":"Circulation."},{"issue":"7","key":"10.1016\/j.cca.2023.117226_b0155","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/s41569-018-0007-y","article-title":"Mechanisms of physiological and pathological cardiac hypertrophy","volume":"15","author":"Nakamura","year":"2018","journal-title":"Nat. Rev. Cardiol."},{"issue":"7","key":"10.1016\/j.cca.2023.117226_b0160","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1046\/j.1365-2362.2003.01169.x","article-title":"Fibrinogen, inflammation and concentric left ventricular hypertrophy in chronic renal failure","volume":"33","author":"Zoccali","year":"2003","journal-title":"Eur. J. Clin. Invest."},{"issue":"10","key":"10.1016\/j.cca.2023.117226_b0165","doi-asserted-by":"crossref","first-page":"2764","DOI":"10.2337\/diacare.26.10.2764","article-title":"Relation of left ventricular hypertrophy to inflammation and albuminuria in adults with type 2 diabetes: the strong heart study","volume":"26","author":"Palmieri","year":"2003","journal-title":"Diabetes. Care."},{"issue":"1","key":"10.1016\/j.cca.2023.117226_b0170","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s12877-017-0411-x","article-title":"Incidence and predictors of left ventricular remodeling among elderly Asian women: a community-based cohort study","volume":"17","author":"Wu","year":"2017","journal-title":"BMC. Geriatr."},{"key":"10.1016\/j.cca.2023.117226_b0175","doi-asserted-by":"crossref","unstructured":"B. Williams, G. Mancia, W. Spiering, et al. 2018 ESC\/ESH Guidelines for the management of arterial hypertension [published correction appears in Eur Heart J. 2019 Feb 1;40(5):475]. Eur. Heart J. 2018;39(33):3021-3104. doi: https:\/\/doi.org\/10.1093\/eurheartj\/ehy339.","DOI":"10.1093\/eurheartj\/ehy339"},{"key":"10.1016\/j.cca.2023.117226_b0180","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.atherosclerosis.2022.02.013","article-title":"How should public health recommendations address Lp(a) measurement, a causative risk factor for cardiovascular disease (CVD)?","volume":"349","author":"Catapano","year":"2022","journal-title":"Atherosclerosis."},{"issue":"4","key":"10.1016\/j.cca.2023.117226_b0185","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1161\/01.CIR.102.4.470","article-title":"Left ventricular hypertrophy: pathogenesis, detection, and prognosis","volume":"102","author":"Lorell","year":"2000","journal-title":"Circulation."},{"issue":"8","key":"10.1016\/j.cca.2023.117226_b0190","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1161\/CIRCRESAHA.107.160457","article-title":"Forgotten but not gone: the rediscovery of fatty heart, the most common unrecognized disease in America","volume":"101","author":"Szczepaniak","year":"2007","journal-title":"Circ. Res."},{"issue":"8","key":"10.1016\/j.cca.2023.117226_b0195","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/s41569-018-0044-6","article-title":"Metabolic remodelling in heart failure","volume":"15","author":"Bertero","year":"2018","journal-title":"Nat. Rev. Cardiol."}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898123000190?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898123000190?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T15:08:47Z","timestamp":1757862527000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898123000190"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":39,"alternative-id":["S0009898123000190"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2023.117226","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of lipoprotein(a) with left ventricular hypertrophy in patients with new-onset acute myocardial infarction: A large cross-sectional study","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2023.117226","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"117226"}}